Tag: presented
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress…
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the…
Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity with a third achieving 25% or more according to data presented at ADA
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or…
Inaugural Archer Amish Award Winner Announced at IGF London 2025
U.K Minister for Culture Lisa Nandy presents $25,000 award to Dr. Shalini Mullick for her novel The Way…
Altius Inspiro Wins 2025 Fortress Cybersecurity Award for Network Security
MANILA, Philippines, June 19, 2025 (GLOBE NEWSWIRE) -- Altius Inspiro, a leader in digital CX and outsourcing solutions, has…
Hyundai Motor Group Announces Grand Prix Recipient and Exhibitions of the 6th VH AWARD
Hyundai Motor Group premieres five commissioned artworks of the 6th VH AWARD screening at HEK (House of Electronic…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma…
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET Â | Source: Celldex Therapeutics, Inc. 77% of patients (150 mg Q4W) treated with…
IIHM Receives National Honour for ‘Excellence in Global Hospitality Education’ from Union Education Minister Dharmendra Pradhan
NEW DELHI, June 9, 2025 /PRNewswire/ -- The International Institute of Hotel Management (IIHM) has added another remarkable…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational…
Startek Wins 2025 Fortress Cybersecurity Award for Organizational Excellence
MUMBAI, India, June 4, 2025 /PRNewswire/ -- Startek®, a digital-first global customer experience (CX) solutions provider, announced today that…
